This reflect that the effect of GLP-1 RA as a class and clinicians should interpret these findings to ensure that the future studies must comprehend detailed information to investigate the potential differences in CRC risk with individual GLP-1 RAs. This evidence concerns the gene GCG and colorectal carcinoma.